1. Adelaide Research & Scholarship

Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 21-30 of 49 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2004Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.Karnon, J.; Peters, J.; Chilcott, J.; McGoogan, E.; Brewer, N.
2013Indirect estimation of the comparative treatment effect in pharmacogenomic subgroupsSorich, M.; Coory, M.; Pekarsky, B.; Dubé, M.
2018Estimating the reference incremental cost-effectiveness ratio for the Australian health systemEdney, L.; Haji Ali Afzali, H.; Cheng, T.; Karnon, J.
2018Model structuring for economic evaluations of new health technologiesHaji Ali Afzali, H.; Bojke, L.; Karnon, J.
2003A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy: for advanced breast cancer in postmenopausal patientsKarnon, J.; Jones, T.
2013A model-based economic evaluation of improved primary care management of patients with type 2 diabetes in AustraliaHajiali Afzali, H.; Gray, J.; Beilby, J.; Holton, C.; Karnon, J.
2021The integration of mixed methods data to develop the quality of life - aged care consumers (QOL-ACC) instrumentHutchinson, C.; Ratcliffe, J.; Cleland, J.; Walker, R.; Milte, R.; McBain, C.; Corlis, M.; Cornell, V.; Khadka, J.
2012Applying risk adjusted cost-effectiveness (RAC-E) analysis to hospitals: estimating the costs and consequences of variation in clinical practiceKarnon, J.; Caffrey, O.; Pham, C.; Grieve, R.; Ben-Tovim, D.; Hakendorf, P.; Crotty, M.
2016Governments need better guidance to maximise value for money: the case of Australia’s Pharmaceutical Benefits Advisory CommitteeCarter, D.A.; Vogan, A.; Haji Ali Afzali, H.
2015Better informing decision making with multiple outcomes cost-effectiveness analysis under uncertainty in cost-disutility spaceMcCaffrey, N.; Agar, M.; Harlum, J.; Karnon, J.; Currow, D.; Eckermann, S.; Feenstra, T.

Discover